DEC-99187-78832 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-28
Dose 1 — Pfizer-BioNTech
2021-06-15
Dose 2 — Pfizer-BioNTech
2021-12-02
Registered in v-safe
2021-12-14
Survey response — 6 months, dose 2, dependent
MedDRA: Full blood count abnormal, Laboratory test abnormal, Lymphadenopathy, Office visit, Red blood cell sedimentation rate increased, Unevaluable event, White blood cell count increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Multiple enlarged axillary lymph nodes on the left side with a thicken of the cortex, elevated sed rate and white blood count as well as other abnormal labs in his Complete Blood Count · Healthcare visit (other): Primary Care visit as well as scheduling with a Pediatric General Surgeon

MedDRA releases: 2024-11 · check-in free text available
2021-12-14
Report sent to call center — 6 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-12-15
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-28	Pfizer-BioNTech	No
2	2021-06-15	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — 6 months, dose 2, dependent

2021-12-14

Symptoms: Multiple enlarged axillary lymph nodes on the left side with a thicken of the cortex, elevated sed rate and white blood count as well as other abnormal labs in his Complete Blood Count

Healthcare visit (other): Primary Care visit as well as scheduling with a Pediatric General Surgeon

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Full blood count abnormal	·	·	✓
SD	Laboratory test abnormal	·	·	✓
SD	Lymphadenopathy	·	·	✓
SD	Red blood cell sedimentation rate increased	·	·	✓
SD	Unevaluable event	·	·	✓
SD	White blood cell count increased	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release